awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36588477-13D37D80-A789-4273-8B29-11DC527A21E1
Q36588477-13D37D80-A789-4273-8B29-11DC527A21E1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36588477-13D37D80-A789-4273-8B29-11DC527A21E1
Blocking MHC class II on human endothelium mitigates acute rejection
P2860
Q36588477-13D37D80-A789-4273-8B29-11DC527A21E1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36588477-13D37D80-A789-4273-8B29-11DC527A21E1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cac0361994cc8c69024020a7e131a7bc2c8f0a1b
P2860
A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients.